| P50 | author | Will Jens | Q81785597 |
| P2093 | author name string | Kevin G Lynch | |
| | Kyle Kampman | |
| | Charles P O'Brien | |
| | Anna Rose Childress | |
| | Teresa R Franklin | |
| | Derek Harper | |
| | Susan Kildea-McCrea | |
| P2860 | cites work | Interventions to reduce harm from continued tobacco use | Q24244287 |
| | Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581] | Q24799720 |
| | A pharmacologic strategy for the treatment of nicotine addiction | Q28569945 |
| | GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine | Q28583003 |
| | Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat | Q28583983 |
| | Role of GABAB receptor in alcohol dependence: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics | Q29395989 |
| | Pharmacological interventions for spasticity following spinal cord injury | Q33900648 |
| | GABA modulation of cocaine self-administration. | Q33981450 |
| | Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician | Q33983758 |
| | Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial | Q33997418 |
| | Factors associated with outcome in unaided smoking cessation, and a comparison of those who have never tried to stop with those who have. | Q34053051 |
| | GABA systems, benzodiazepines, and substance dependence | Q34186581 |
| | Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons | Q34533236 |
| | Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex | Q34659349 |
| | Quitting smoking: estimation by meta-analysis of the rate of unaided smoking cessation. | Q34722589 |
| | Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study | Q34722965 |
| | A meta-analysis of the efficacy of over-the-counter nicotine replacement | Q35075620 |
| | DAT genotype modulates brain and behavioral responses elicited by cigarette cues. | Q35947872 |
| | Neural mechanisms of drug reinforcement | Q36330262 |
| | Bupropion for the treatment of nicotine withdrawal and craving | Q36532139 |
| | Is there a health benefit of reduced tobacco consumption? A systematic review | Q36844983 |
| | Baclofen as prophylaxis and treatment for alcohol withdrawal: a retrospective chart review | Q37004312 |
| | Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. | Q38405712 |
| | Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire | Q38674138 |
| | Clinical and pharmacokinetic aspects of high dose oral baclofen therapy | Q39499286 |
| | Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence | Q40320100 |
| | The role of dopamine in drug abuse viewed from the perspective of its role in motivation | Q40480641 |
| | Relationships among physiological and self-report responses produced by cocaine-related cues | Q40902257 |
| | The dopamine transporter: a crucial component regulating dopamine transmission. | Q41649915 |
| | Smoking cessation with and without assistance: a population-based analysis | Q41733103 |
| | A novel strategy for the treatment of cocaine addiction | Q42540010 |
| | Two behavioral treatments for smoking reduction: a pilot study | Q43549142 |
| | Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking | Q43638196 |
| | A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis | Q43753785 |
| | GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. | Q43794898 |
| | The effect of bupropion sustained-release on cigarette craving after smoking cessation | Q43997773 |
| | Baclofen antagonizes intravenous self-administration of nicotine in mice and rats | Q44129395 |
| | Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study | Q44129398 |
| | Harm reduction--a treatment approach for resistant smokers with tobacco-related symptoms | Q44136881 |
| | Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area | Q44331544 |
| | The GABA B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat | Q44650861 |
| | Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. | Q44731806 |
| | Lioresal (baclofen) treatment of spasticity in multiple sclerosis | Q44814871 |
| | Safety and efficacy of GABAergic medications for treating alcoholism | Q44908433 |
| | Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation | Q45150048 |
| | Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents | Q46105225 |
| | Smoking topography, brand switching, and nicotine delivery: results from an in vivo study | Q46533309 |
| | Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt | Q46846934 |
| | Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study | Q47836585 |
| | Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release | Q48131620 |
| | Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine | Q48206896 |
| | Implication of the GABA(B) receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine | Q48280736 |
| | The GABAB agonist baclofen modifies cocaine self-administration in rats. | Q48340029 |
| | Suppression of symptoms of alcohol dependence and craving using high-dose baclofen | Q48420812 |
| | Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving | Q48421523 |
| | Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. | Q48496653 |
| | Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine | Q48574637 |
| | The effect of bupropion on nicotine craving and withdrawal | Q48732462 |
| | Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure | Q48748425 |
| | GABAergic attenuation of cocaine-induced dopamine release and locomotor activity | Q48751140 |
| | Effects of GABA agonists and GABA-A receptor modulators on cocaine discrimination in rhesus monkeys. | Q51369281 |
| | Baclofen as a cocaine anti-craving medication: a preliminary clinical study. | Q51526312 |
| | Baclofen attenuates the reinforcing effects of cocaine in rats. | Q51561412 |
| | The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. | Q51988203 |
| | Is craving the source of compulsive drug use? | Q52243507 |
| | Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. | Q52291155 |
| | Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. | Q52893441 |
| | Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence. | Q52893445 |
| | Nurse-conducted smoking cessation with minimal intervention in a lung clinic: a randomized controlled study. | Q52906951 |
| | Effect of Smoking Reduction on Lung Cancer Risk | Q61875233 |
| | Nicotine yield as determinant of smoke exposure indicators and puffing behavior | Q67837160 |
| | Intracellular recording from putative dopamine-containing neurons in the ventral tegmental area of Tsai in a brain slice preparation | Q69616672 |
| | [Reduced smoking--a possible strategy for control of tobacco-associated illnesses?] | Q73342884 |
| | Reduction and cessation of cigarette smoking and risk of cancer: a cohort study of Korean men | Q82222815 |
| P433 | issue | 1-2 | |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 30-36 | |
| P577 | publication date | 2009-04-23 | |
| P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
| P1476 | title | The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study | |
| P478 | volume | 103 | |